122 related articles for article (PubMed ID: 8735607)
1. Estrogen-induced changes in rRNA accumulation and RNA polymerase I activity in the rat pituitary: correlation with pituitary tumor susceptibility.
Ying C; Gregg DW; Gorski J
Mol Cell Endocrinol; 1996 Apr; 118(1-2):207-13. PubMed ID: 8735607
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of carboxypeptidase E protein is correlated to estrogen-induction of rat pituitary tumors.
Gregg D; Goedken E; Gaikin M; Wendell D; Gorski J
Mol Cell Endocrinol; 1996 Mar; 117(2):219-25. PubMed ID: 8737383
[TBL] [Abstract][Full Text] [Related]
3. Potential involvement of tumor suppressor gene expression in the formation of estrogen-inducible pituitary tumors in rats.
Ying C
Endocr J; 2000 Feb; 47(1):1-5. PubMed ID: 10811286
[TBL] [Abstract][Full Text] [Related]
4. Estrogen induction of prolactin-producing pituitary tumors in the Fischer 344 rat: modulation by dietary-energy but not protein consumption.
Shull JD; Birt DF; McComb RD; Spady TJ; Pennington KL; Shaw-Bruha CM
Mol Carcinog; 1998 Oct; 23(2):96-105. PubMed ID: 9808163
[TBL] [Abstract][Full Text] [Related]
5. Genetic differences in estrogen-induced deoxyribonucleic acid synthesis in the rat pituitary: correlations with pituitary tumor susceptibility.
Wiklund JA; Gorski J
Endocrinology; 1982 Oct; 111(4):1140-9. PubMed ID: 7117195
[TBL] [Abstract][Full Text] [Related]
6. Estrogen-dependent growth of a rat pituitary tumor involves, but does not require, a high level of vascular endothelial growth factor.
Cracchiolo D; Swick JW; McKiernan L; Sloan E; Raina S; Sloan C; Wendell DL
Exp Biol Med (Maywood); 2002 Jul; 227(7):492-9. PubMed ID: 12094014
[TBL] [Abstract][Full Text] [Related]
7. Effect of estrogen on the expression of galanin mRNA in pituitary tumor-sensitive and tumor-resistant rat strains.
Gregg DW; Galkin M; Gorski J
Steroids; 1996 Aug; 61(8):468-72. PubMed ID: 8870166
[TBL] [Abstract][Full Text] [Related]
8. Temporal effects of estradiol and diethylstilbestrol on pituitary and plasma prolactin levels in ovariectomized Fischer 344 and Holtzman rats: a comparison of radioimmunoassay and Nb2 lymphoma cell bioassay.
Moy J; Lawson D
Proc Soc Exp Biol Med; 1992 Sep; 200(4):507-13. PubMed ID: 1508941
[TBL] [Abstract][Full Text] [Related]
9. Increased activity of type I regulatory subunit of cyclic adenosine 3',5'-monophosphate-dependent protein kinase in estrogen-induced pituitary tumors.
Piroli G; Pignataro O; De Nicola AF
J Natl Cancer Inst; 1992 Oct; 84(20):1565-71. PubMed ID: 1328659
[TBL] [Abstract][Full Text] [Related]
10. Glandular kallikrein in estrogen-induced pituitary tumors: time course of induction and correlation with prolactin.
Hatala MA; Powers CA
Cancer Res; 1988 Aug; 48(15):4158-62. PubMed ID: 3390808
[TBL] [Abstract][Full Text] [Related]
11. Genetic separation of tumor growth and hemorrhagic phenotypes in an estrogen-induced tumor.
Wendell DL; Herman A; Gorski J
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):8112-6. PubMed ID: 8755612
[TBL] [Abstract][Full Text] [Related]
12. Suppression of estrogen-dependent MMP-9 expression by Edpm5, a genetic locus for pituitary tumor growth in rat.
Sclafani RV; Wendell DL
Mol Cell Endocrinol; 2001 May; 176(1-2):145-53. PubMed ID: 11369454
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-induced rat pituitary tumor is associated with loss of retinoblastoma susceptibility gene product.
Chun TY; Wendell D; Gregg D; Gorski J
Mol Cell Endocrinol; 1998 Nov; 146(1-2):87-92. PubMed ID: 10022766
[TBL] [Abstract][Full Text] [Related]
14. Effects of nitric oxide synthase inhibition on diethylstilbestrol-induced hyperprolactinaemia and pituitary tumourigenesis in rats.
Pawlikowski M; Pisarek H; Fryczak J; Stępień H
Endokrynol Pol; 2012; 63(2):115-8. PubMed ID: 22538750
[TBL] [Abstract][Full Text] [Related]
15. Global analysis of gene expression in the estrogen induced pituitary tumor of the F344 rat.
Wendell DL; Platts A; Land S
J Steroid Biochem Mol Biol; 2006 Nov; 101(4-5):188-96. PubMed ID: 17005392
[TBL] [Abstract][Full Text] [Related]
16. Autocrine/paracrine action of pituitary vasoactive intestinal peptide on lactotroph hyperplasia induced by estrogen.
Gómez O; Balsa JA
Endocrinology; 2003 Oct; 144(10):4403-9. PubMed ID: 12960047
[TBL] [Abstract][Full Text] [Related]
17. Exposure of newborn male and female rats to environmental estrogens: delayed and sustained hyperprolactinemia and alterations in estrogen receptor expression.
Khurana S; Ranmal S; Ben-Jonathan N
Endocrinology; 2000 Dec; 141(12):4512-7. PubMed ID: 11108262
[TBL] [Abstract][Full Text] [Related]
18. Implication of pituitary vasoactive intestinal peptide in dopaminergic inhibition of estrogen-induced pituitary hyperplasia and vascular endothelial growth factor expression.
Gómez O; Balsa JA
Neuroendocrinology; 2004; 80(5):324-31. PubMed ID: 15677882
[TBL] [Abstract][Full Text] [Related]
19. Protein and RNA synthesis in pituitary tumors from F344 rats given implants of estrogen.
Kaplan SE; De Nicola AF
J Natl Cancer Inst; 1976 Jan; 56(1):37-42. PubMed ID: 1255750
[TBL] [Abstract][Full Text] [Related]
20. Time course of induction of prolactin-secreting pituitary tumors with diethylstilbestrol in male rats: response of tuberoinfundibular dopaminergic neurons.
Morgan WW; Steger RW; Smith MS; Bartke A; Sweeney CA
Endocrinology; 1985 Jan; 116(1):17-24. PubMed ID: 3917247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
